Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • apa.csl
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Longitudinellt perspektiv på symtomatisk remission vid schizofreni
Karlstad University, Faculty of Arts and Social Sciences (starting 2013), Department of Social and Psychological Studies (from 2013). VGR NU-sjukvården.
2023 (Swedish)Doctoral thesis, comprehensive summary (Other academic)Alternative title
Longitudinal perspective on symptomatic remission in Schizophrenia (English)
Abstract [en]

Objective: The overall aim of this thesis was to investigate the remission criteria according to the Remisson in Schizophrenia Working Group (RWSG), mainly from a longitudinal perspective.

Paper I showed that all remission symptoms in the RSWG criteria, affected the remission status in the cross-sectional setting. In the longitudinal setting, the symptoms Delusions and Hallucinatory behavior contributed mostly to the fluctuation between remission and non-remission, while negative symptoms were more prominent in the group that never reached remission. Finally, the sustainability of remission was significantly longer when only minimal symptom intensity occurred, compared with mild.

Paper II showed that the cognitive areas associated with long-term remission pattern were executive functioning, working memory and verbal functioning, where significant better results were shown in the group of stable remission with only minimal symptoms compared to the group never reaching remission. Verbal functioning was the only cognitive area that could predict long-term remission pattern, as a better result increased the probability of being in long-term remission.

Paper III focused on the patient’s perspective and examined the relationship between subjective quality of life (SQoL) and remission. The paper showed significant associations between a better SQoL, self-assessed with Short Form Health Survey-36, and both cross-sectional remission and long-term. A significant better SQoL was present regardless of being in stable remission over time or if remission was reached during the study period.

Conclusions: The thesis support that the RSWG criteria for remission is a valuable concept, also from a longitudinal perspective. Taken together, the results emphasize the heterogeneity of schizophrenia, where different groups within the disorder show different clinical characteristics. This thesis highlights the importance of regular assessments of broad clinical status, to support a higher frequency and sustainability of remission.

Abstract [sv]

I denna avhandling granskas remissionskriterierna enligt Remission Schizophrenia Working Group (RSWG) för personer med schizofreni ur ett longitudinellt perspektiv.

Studie I visade att alla inkluderade symtom i RSWG-kriterierna bidrog till att avgöra remissionsstatus. Negativa symtom bidrog mest till förekomsten av icke-remission över tid, medan växlingen mellan remission och icke-remission varierade mer med positiva symtom. En ökad hållbarhet i remission förelåg vid en minimal symtomintensitet, jämfört med en mild. 

Studie II visade att patienterna i stabil remission hade bättre kognitiv funktion, jämfört med de som aldrig var i remission. Ju bättre verbal funktion desto högre sannolikhet förelåg dessutom att tillhöra gruppen i stabil remission över tid. 

Studie III visade att den subjektiva livskvaliteten (SQoL) var bättre vid remission jämfört med icke-remission. En bättre SQoL förelåg oavsett om remissionsförekomsten över tid var stabil eller om den uppnåddes under studieperioden, både för den mentala och fysiska hälsan. 

Avhandlingen stöder remissionskriteriernas användbarhet ur ett longitudinellt perspektiv, och återspeglar sjukdomens heterogenitet. Avhandlingen poängterar vikten av att systematiskt följa upp de i avhandlingen undersökta faktorerna för att öka förekomsten samt hållbarheten i symtomatisk remission. 

Place, publisher, year, edition, pages
Karlstads universitet, 2023. , p. 130
Series
Karlstad University Studies, ISSN 1403-8099 ; 2023:14
Keywords [en]
Cognitive Functioning, Longitudinal, RSWG Criteria, Schizophrenia Spectrum Disorders, Subjective Quality of Life, Symptomatic Remission
Keywords [sv]
Kognitiv funktion, longitudinell, RSWG-kriterier, schizofrenispektrumsyndrom, symtomatisk remission, subjektiv livskvalitet
National Category
Other Medical Sciences not elsewhere specified
Research subject
Psychology
Identifiers
URN: urn:nbn:se:kau:diva-94296ISBN: 978-91-7867-370-4 (print)ISBN: 978-91-7867-371-1 (electronic)OAI: oai:DiVA.org:kau-94296DiVA, id: diva2:1750961
Public defence
2023-06-09, 11D257, Agardhsalen, Universitetsgatan 2, Karlstad, 10:00 (Swedish)
Opponent
Supervisors
Projects
Clinical Longterm Investigation of Psychosis in Sweden (CLIPS)Available from: 2023-05-12 Created: 2023-04-14 Last updated: 2023-06-20Bibliographically approved
List of papers
1. What could be learned from a decade with standardized remission criteria in schizophrenia spectrum disorders: An exploratory follow-up study
Open this publication in new window or tab >>What could be learned from a decade with standardized remission criteria in schizophrenia spectrum disorders: An exploratory follow-up study
2018 (English)In: Schizophrenia Research, ISSN 0920-9964, E-ISSN 1573-2509, Vol. 195, no May, p. 103-109Article in journal (Refereed) Published
Abstract [en]

A decade has passed since the standardized remission criteria of schizophrenia spectrum disorders-the Andreasen Criteria-were defined. Over 2000 studies have been published, but only a few describe symptomatic remission over time. In this prospective study we followed patients for 3 and 5 years, respectively. The aim was to investigate how different symptoms affect the occurrence of remission and how the remission cut-off level affects remission sustainability. The participants were patients diagnosed with schizophrenia spectrum disorders (DSM-IV). First, the importance of each core symptom for remission was examined using the Positive and Negative Syndrome Scale (n = 274). Second, we investigated which items affect patients to either go in and out of remission or never achieve remission (n = 154). Third, we investigated how the sustainability of remission is affected by a cut-off set to 2 (minimal) and 3 (mild) points, respectively (n = 154). All core symptoms affected the occurence of remission, to a higher or lesser extent. Delusions and Hallucinatory behavior contributed the strongest to fluctuation between remission and non-remission, while the contribution of Mannerism and posturing was very marginal. Negative symptoms were enhanced when remission was never achieved. Moreover, the study found that remission duration was significantly longer for the cut-off score 2 rather than 3. The study shows that, over time, remission criteria discriminate between being stable, unstable, or never in remission. Patients with only a minimal occurrence of symptom intensity exhibit a significantly longer remission duration compared to patients with mild symptom intensity, indicating that the treatment goal should be minimal symptom intensity.

Place, publisher, year, edition, pages
Elsevier, 2018
Keywords
Symptomatic remission; Sustainability; Schizophrenia spectrum disorders
National Category
Psychiatry
Research subject
Psychology
Identifiers
urn:nbn:se:kau:diva-67421 (URN)10.1016/j.schres.2017.09.007 (DOI)000432466700015 ()28899583 (PubMedID)
Available from: 2018-05-31 Created: 2018-05-31 Last updated: 2023-04-27Bibliographically approved
2. Cognitive markers related to long-term remission status in Schizophrenia Spectrum Disorders
Open this publication in new window or tab >>Cognitive markers related to long-term remission status in Schizophrenia Spectrum Disorders
2020 (English)In: Psychiatry Research, ISSN 0165-1781, E-ISSN 1872-7123, Vol. 289, article id 113035Article in journal (Refereed) Published
Abstract [en]

Cognitive impairment is an established feature of schizophrenia. From a cross-sectional perspective, studies have revealed associations between cognition and remission. Few studies have examined this relationship longitudinally. Here we examine which cognitive domains might be related to long-term remission and symptomatic severity. The present study followed 173 outpatients with schizophrenia for five years, divided into groups based on long-term remission status and symptomatic severity, assessed with the Positive and Negative Syndrome Scale. Cognitive functioning was assessed at baseline, with tests of vigilance, executive functions, processing speed, memory and learning, working memory, and premorbid functioning. Cognitive domains related to long-term remission status were executive functions, working memory, and premorbid functioning. The most prominent cognitive differences were found between the group in stable remission with minimal symptoms, and the non-remission group, the first group demonstrating better cognitive functioning. The study highlights the role of premorbid functioning as a cognitive feature in the prediction of long-term remission. It also indicates the possibility of viewing specific cognitive domains as markers for clinical outcome, highlighting the value of early assessment of cognition. In summary, a certain cognitive profile, in coexistence with long-term non-remission, suggests poorer outcome. Hence, this group is in need of increased support.

Place, publisher, year, edition, pages
Elsevier, 2020
Keywords
adult, alertness, Article, clinical outcome, cognition assessment, controlled study, cross-sectional study, disease severity, executive function, female, human, long term care, longitudinal study, major clinical study, male, middle aged, Positive and Negative Syndrome Scale, priority journal, processing speed, prognosis, remission, schizophrenia spectrum disorder, symptom, task performance, working memory
National Category
Psychiatry
Research subject
Psychology
Identifiers
urn:nbn:se:kau:diva-78308 (URN)10.1016/j.psychres.2020.113035 (DOI)000558423200015 ()2-s2.0-85084820475 (Scopus ID)
Available from: 2020-06-15 Created: 2020-06-15 Last updated: 2023-04-27Bibliographically approved
3. Exploring cross-sectional and longitudinal symptomatic remission and subjective quality of life in Schizophrenia
Open this publication in new window or tab >>Exploring cross-sectional and longitudinal symptomatic remission and subjective quality of life in Schizophrenia
2023 (English)In: Psychiatry Research, ISSN 0165-1781, E-ISSN 1872-7123, Vol. 328, article id 115421Article in journal (Refereed) Published
Abstract [en]

Achieving symptomatic remission, as defined by the Remission in Schizophrenia Working Group, is intended tobe a meaningful outcome for individuals with schizophrenia, resulting in enhanced well-being. Cross-sectionalstudies have reported an association between symptomatic remission and subjective quality of life (QoL). Longitudinal studies aimed at examining this association have showed mixed results. The aim of this study was toexplore the relationship between symptomatic remission and subjective QoL, both cross-sectionally andlongitudinally. The study comprised data from what were at most 386 patients with schizophrenia, of whom 122–140 werefollowed over a period of four years. Based on cross-sectional remission status and longitudinal remissionpattern, differences in subjective QoL were explored. Remission status was assessed using the Positive andNegative Syndrome Scale (PANSS), and subjective QoL using the Short Form-36 Health Survey (SF-36). Both the cross-sectional and the longitudinal approach showed that patients in symptomatic remission hadsignificantly higher subjective QoL. Patients who were in non-remission at baseline, but who achieved remissionat follow-up, also had significantly higher subjective QoL at follow-up compared with baseline. The results from the study show a clear association between symptomatic remission and subjective QoL. However, achieving symptomatic remission does not appear to be a guarantee of sustained subjective QoL, andonly continued stable remission appears to result in such an outcome.

Place, publisher, year, edition, pages
Elsevier, 2023
Keywords
Longitudinal, Schizophrenia Spectrum Disorder, Subjective Quality of Life, Symptomatic Remission
National Category
Other Medical Sciences not elsewhere specified Psychiatry
Research subject
Psychology
Identifiers
urn:nbn:se:kau:diva-94294 (URN)10.1016/j.psychres.2023.115421 (DOI)001076677100001 ()37659163 (PubMedID)2-s2.0-85170063321 (Scopus ID)
Note

This paper was included as a manuscripts in Madeleine Johansson's doctoral thesis entitled 'Longitudinellt perspektiv på symtomatisk remission vid schizofreni' 2023:14. 

Available from: 2023-04-14 Created: 2023-04-14 Last updated: 2023-11-02Bibliographically approved

Open Access in DiVA

fulltext(1200 kB)272 downloads
File information
File name FULLTEXT01.pdfFile size 1200 kBChecksum SHA-512
0b95ef72aedf0ee5f9865cc83e678804d95e77ae639c9b3885c4c69f24ed630ca586c6a30fd786fd7f19c23163929f3bc0b841bcd625979c0ce1d6d4d37db09f
Type fulltextMimetype application/pdf

Authority records

Johansson, Madeleine

Search in DiVA

By author/editor
Johansson, Madeleine
By organisation
Department of Social and Psychological Studies (from 2013)
Other Medical Sciences not elsewhere specified

Search outside of DiVA

GoogleGoogle Scholar
Total: 272 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

isbn
urn-nbn

Altmetric score

isbn
urn-nbn
Total: 722 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • apa.csl
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf